Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rafael Esteban

Showing results (41-50 of 224) with videos related to

Pageof 23
Sort By:
Journal of Hepatology|July 7, 2009
Modeling the cost-effectiveness of different oral antiviral therapies in patients with chronic hepatitis BMaria Buti, Max Brosa, Miguel A Casado, et al.
Clinical and Molecular Hepatology|November 11, 2024
Hepatitis E as a trigger for acute-on-chronic liver failureMaria Buti, Juan Carlos Ruiz-Cobo, Rafael Esteban, et al.
International Urology and Nephrology|November 8, 2007
De novo nephrotic syndrome following pegylated interferon alfa 2b/ribavirin therapy for chronic hepatitis C infectionJose L Tovar, Maria Buti, Alfonso Segarra, et al.
Seminars in Liver Disease|December 6, 2019
Role of Biomarkers in Guiding Cure of Viral Hepatitis BMaria Buti, Mar Riveiro-Barciela, Francisco Rodríguez-Frías, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 2, 2023
Impact of hepatitis D reflex testing on the future disease burden: A modelling analysisMaria Buti, Raquel Domínguez-Hernández, Adriana Palom, et al.
Journal of Hepatology|September 20, 2005
Neuropsychological abnormalities in cirrhosis include learning impairmentMaría Ortiz, Juan Córdoba, Carlos Jacas, et al.
Hepatology (Baltimore, Md.)|August 3, 2013
Study of hepatitis B virus quasispecies by ultra-deep pyrosequencing: Resolving the nitty-grittyFrancisco Rodriguez-Frias, Francisco-Rodriguez Frias, David Tabernero, et al.
Plos One|November 29, 2018
Healthcare value of implementing hepatitis C screening in the adult general population in SpainMaría Buti, Raquel Domínguez-Hernández, Miguel Ángel Casado, et al.
Infection and Drug Resistance|June 23, 2011
New strategies for the treatment of hepatitis C virus infection and implications of resistance to new direct-acting antiviral agentsJosep Quer, Maria Buti, Maria Cubero, et al.
Revista Espanola De Enfermedades Digestivas|June 27, 2017
Cost-effectiveness of a hepatitis B virus screening strategy to prevent reactivation in patients with hematologic neoplasmsJavier Crespo, Rafael Esteban, Covadonga Torres, et al.
Pageof 23

Showing results (41-50 of 224) with videos related to

Sort By:
Pageof 23
Journal of Hepatology|July 7, 2009
Modeling the cost-effectiveness of different oral antiviral therapies in patients with chronic hepatitis BMaria Buti, Max Brosa, Miguel A Casado, et al.
Clinical and Molecular Hepatology|November 11, 2024
Hepatitis E as a trigger for acute-on-chronic liver failureMaria Buti, Juan Carlos Ruiz-Cobo, Rafael Esteban, et al.
International Urology and Nephrology|November 8, 2007
De novo nephrotic syndrome following pegylated interferon alfa 2b/ribavirin therapy for chronic hepatitis C infectionJose L Tovar, Maria Buti, Alfonso Segarra, et al.
Seminars in Liver Disease|December 6, 2019
Role of Biomarkers in Guiding Cure of Viral Hepatitis BMaria Buti, Mar Riveiro-Barciela, Francisco Rodríguez-Frías, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 2, 2023
Impact of hepatitis D reflex testing on the future disease burden: A modelling analysisMaria Buti, Raquel Domínguez-Hernández, Adriana Palom, et al.
Journal of Hepatology|September 20, 2005
Neuropsychological abnormalities in cirrhosis include learning impairmentMaría Ortiz, Juan Córdoba, Carlos Jacas, et al.
Hepatology (Baltimore, Md.)|August 3, 2013
Study of hepatitis B virus quasispecies by ultra-deep pyrosequencing: Resolving the nitty-grittyFrancisco Rodriguez-Frias, Francisco-Rodriguez Frias, David Tabernero, et al.
Plos One|November 29, 2018
Healthcare value of implementing hepatitis C screening in the adult general population in SpainMaría Buti, Raquel Domínguez-Hernández, Miguel Ángel Casado, et al.
Infection and Drug Resistance|June 23, 2011
New strategies for the treatment of hepatitis C virus infection and implications of resistance to new direct-acting antiviral agentsJosep Quer, Maria Buti, Maria Cubero, et al.
Revista Espanola De Enfermedades Digestivas|June 27, 2017
Cost-effectiveness of a hepatitis B virus screening strategy to prevent reactivation in patients with hematologic neoplasmsJavier Crespo, Rafael Esteban, Covadonga Torres, et al.
Pageof 23